Skip to main content
Clinical Trials/NCT00298311
NCT00298311
Completed
N/A

An RCT to Evaluate the Effect of Home-Based Peer Support on Maternal-Infant Interaction, Infant Health Outcomes, and Postpartum Depression

Canadian Research Institute for Social Policy0 sites60 target enrollmentNovember 2005

Overview

Phase
N/A
Intervention
Not specified
Conditions
Postpartum Depression
Sponsor
Canadian Research Institute for Social Policy
Enrollment
60
Primary Endpoint
maternal-infant interaction
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The objective of this study is to examine the impact of a home-based peer support intervention for mothers affected by postpartum depression (PPD) and for their infants.

Detailed Description

This controlled study will help establish the link between support for maternal caregiving, maternal-infant interaction, infant neuroendocrinology and infant cognitive and social development. The primary hypothesis predicts that home-based peer support will improve maternal-infant interactions. Secondary hypotheses predict that home-based peer support will: improve infants' cognitive development; improve infants' social development; decrease average daily salivary cortisol levels in infants; reduce maternal depressive symptomatology; and improve maternal perceptions of social support.

Registry
clinicaltrials.gov
Start Date
November 2005
End Date
July 2010
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Sponsor
Canadian Research Institute for Social Policy
Responsible Party
Principal Investigator
Principal Investigator

Dr. Nicole LeTourneau

Professor

University of Calgary

Eligibility Criteria

Inclusion Criteria

  • Eligible mothers will be identified as experiencing symptoms of PPD and scores \>12 on the Edinburgh Postnatal Depression Scale.
  • Mothers must speak English or French.
  • Mothers will not be excluded for taking anti-depressant or anti-psychotic medication, using other interventions for PPD, or reporting a history of mental illness;
  • The infant must be full-term, in the care of the mother and between 3 to 6 months of age at initial enrollment.

Exclusion Criteria

  • Infants who have been admitted to the NICU
  • Infants will be excluded if medicated with corticosteroids

Outcomes

Primary Outcomes

maternal-infant interaction

Time Frame: 12 months

Secondary Outcomes

  • cognitive development(12 months)
  • social development(12 months)
  • salivary cortisol(12 months)
  • depressive symptomatology(12 months)
  • social support(12 months)

Similar Trials